Alpha Lipoic Acid 25mg/mL, 30mL-vial, Refrigerate, Tailor Made Compounding
Published July 20, 2022 · Recall initiated: March 7, 2022
Summary
FDA records drug Class II recall D-1192-2022, published July 20, 2022 and initiated March 7, 2022. Recalling firm: TMC Acquisition LLC dba Tailor Made Compounding; Status: Ongoing; Reported quantity: 29 vials; Lot: Batch #: 12082102A2, Exp 3/8/2022; 02212201A1, Exp 5/22/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Batch #: 12082102A2, Exp 3/8/2022; 02212201A1, Exp 5/22/2022.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEstradiol Cypionate 10mg/mL, a) 1mL-vial, b) 2 mL-vial, Room Temperature, Tailor Made CompoundingJuly 20, 2022
- FDASemaglutide/Cyanocobalamin 5mg/0.2mg/ml, 2ml-vial, Refrigerate, Tailor Made CompoundingJuly 20, 2022
- FDAProcaine HCL 2% (20mg/mL), 30 ml-vial, Refrigerate, Tailor Made CompoundingJuly 20, 2022
- FDAGAC (Glutamine/Arginine/L-Carnitine) 25mg/100mg/250mg/mL, 30mL-vial, Refrigerate, Tailor Made CompoundingJuly 20, 2022
- FDAHydrogen Peroxide Topical Solution, USP, 32 fl. oz. (1 QT) 946 mL, Distributed by: CVS Pharmacy, Inc. One CVSJuly 20, 2022
- FDAAlprostadil/Papaverine/Phentolamine 60mcg/30mg/3mg/mL, 3mL-vial, Refrigerate, Tailor Made CompoundingJuly 20, 2022
Questions about this recall
Was Alpha Lipoic Acid 25mg/mL, 30mL-vial, Refrigerate, Tailor Made Compounding recalled?
Yes. FDA published recall D-1192-2022 on July 20, 2022. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter